Brean Murray Carret & Co. Starts Edwards Lifesciences (EW) at Hold; Pole Position Makes EW a Good Story, but Valuation Limited Rate of Price Appreciation

Brean Murray Carret & Co. initiates coverage on Edwards Lifesciences (NYSE: EW) with a Hold.

Brean analyst says, "EW Lifesciences has the lead technology and market position in aortic transcatheter heart values, arguably the most exciting opportunity in Med Tech today."

For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $85.58 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
• ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
• Piper Sandler Starts SoFi Technologies (SOFI) at Overweight